Circulating levels of both Th1 and Th2 chemokines are elevated in patients with sarcoidosis

Respiratory Medicine

Volumn 102, Issue 2, 2008, Pages 239-247

  Nureki, Shin ichi ^a   Miyazaki, Eishi ^a   Ando, Masaru ^a   Ueno, Takuya ^a   Fukami, Tetsujiro ^a   Kumamoto, Toshihide ^a   Sugisaki, Katsunori ^b   Tsuda, Tomiyasu ^c  

^a OITA UNIVERSITY   (Japan)

^b Nishibeppu National Hospital   (Japan)

^c Shinbeppu Hospital   (Japan)

Author keywords

CC chemokine receptor 4; CXC chemokine receptor 3; Interferon inducible protein 10; Sarcoidosis; Thymus and activation regulated chemokine

Indexed keywords

CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON INDUCIBLE PROTEIN 10; THYMUS AND ACTIVATION REGULATED CHEMOKINE;

ADULT; AGED; ARTICLE; CD4+ T LYMPHOCYTE; CELL CULTURE; CIRCULATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SARCOIDOSIS; TH1 CELL; TH2 CELL;

ADULT; AGED; AGED, 80 AND OVER; BRONCHOALVEOLAR LAVAGE FLUID; CD4-POSITIVE T-LYMPHOCYTES; CHEMOKINE CCL17; CHEMOKINE CXCL10; CHEMOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; RECEPTORS, CCR4; RECEPTORS, CXCR3; SARCOIDOSIS, PULMONARY; TH1 CELLS; TH2 CELLS;

EID: 37349032170     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2007.09.006     Document Type: Article

References (40)

1. Mitchell D.N., and Scadding J.G. Sarcoidosis. Am Rev Respir Dis 110 (1974) 774-802
2. Pinkston P., Bitterman P.B., and Crystal R.G. Spontaneous release of interleukin-2 by lung T lymphocytes in active pulmonary sarcoidosis. N Engl J Med 308 (1983) 793-800
3. Robinson B.W., McLemore T.L., and Crystal R.G. Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis. J Clin Invest 75 (1985) 1488-1495
4. Baumer I., Zissel G., Schlaak M., and Müller-Quernheim J. Th1/Th2 cell distribution in pulmonary sarcoidosis. Am J Respir Cell Mol Biol 161 (1997) 171-177
5. Moller D.R., Forman J.D., Liu M.C., et al. Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis. J Immunol 156 (1996) 4952-4960
6. Shigehara K., Shijubo N., Ohmichi M., et al. IL-12 and IL-18 are increased and stimulate IFN-gamma production in sarcoid lungs. J Immunol 166 (2001) 642-649
7. Fukami T., Miyazaki E., Matsumoto T., Kumamoto T., and Tsuda T. Elevated expression of interleukin-18 in the granulomatous lesions of muscular sarcoidosis. Clin Immunol 101 (2001) 12-20
8. Inui N., Chida K., Suda T., and Nakamura H. TH1/TH2 and TC1/TC2 profiles in peripheral blood and bronchoalveolar lavage fluid cells in pulmonary sarcoidosis. J Allergy Clin Immunol 107 (2001) 337-344
9. Wahlström J., Katchar K., Wigzell H., Olerup O., Eklund A., and Grunewald J. Analysis of intracellular cytokines in CD4+ and CD8+ lung and blood T cells in sarcoidosis. Am J Respir Crit Care Med 163 (2001) 115-121
10. Shigehara K., Shijubo N., Ohmichi M., et al. Increased levels of interleukin-18 in patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 162 (2000) 1979-1982
11. Shigehara K., Shijubo N., Ohmichi M., et al. Increased circulating interleukin-12 (IL-12) p40 in pulmonary sarcoidosis. Clin Exp Immunol 132 (2003) 152-157
12. Hauber H.P., Gholami D., Meyer A., and Pforte A. Increased interleukin-13 expression in patients with sarcoidosis. Thorax 58 (2003) 519-524
13. Kaplan A.P. Chemokines, chemokine receptors and allergy. Int Arch Allergy Immunol 124 (2001) 423-431
14. Loetscher M., Gerber B., Loetscher P., et al. Chemokine receptor specific for IP-10 and Mig: structure, function, and expression in activated T-lymphocytes. J Exp Med 184 (1996) 963-969
15. Weng Y., Siciliano S.J., Waldburger K.E., et al. Binding and functional properties of recombinant and endogenous CXCR3 chemokine receptors. J Biol Chem 273 (1998) 18288-18291
16. Narumi S., and Hamilton T.A. Inducible expression of murine IP-10 mRNA varies with the state of macrophage inflammatory activity. J Immunol 146 (1991) 3038-3044
17. Agostini C., Cassatella M., Zambello R., et al. Involvement of the IP-10 chemokine in sarcoid granulomatous reactions. J Immunol 161 (1998) 6413-6420
18. Imai T., Baba M., Nishimura M., Kakizaki M., Takagi S., and Yoshie O. The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J Biol Chem 272 (1997) 15036-15042
19. Imai T., Nagira M., Takagi S., et al. Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. Int Immunol 11 (1999) 81-88
20. Sekiya T., Miyamasu M., Imanishi M., et al. Inducible expression of a Th2-type CC chemokine thymus- and activation-regulated chemokine by human bronchial epithelial cells. J Immunol 165 (2000) 2205-2213
21. Miyazaki E., Nureki S., Fukami T., et al. Elevated levels of thymus- and activation-regulated chemokine in bronchoalveolar lavage fluid from patients with eosinophilic pneumonia. Am J Respir Crit Care Med 165 (2002) 1125-1131
22. Nureki S., Miyazaki E., Ando M., Kumamoto T., and Tsuda T. CC chemokine receptor 4 ligand production by bronchoalveolar lavage fluid cells in cigarette-smoke-associated acute eosinophilic pneumonia. Clin Immunol 116 (2005) 83-93
23. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 160 (1999) 736-755
24. Antoniou K.M., Tzouvelekis A., Alexandrakis M.G., et al. Different angiogenic activity in pulmonary sarcoidosis and idiopathic pulmonary fibrosis. Chest 130 (2006) 982-988
25. Katoh S., Fukushima K., Matsumoto N., et al. Accumulation of CXCR3-expressing eosinophils and increased concentration of its ligands (IP-10 and Mig) in bronchoalveolar lavage fluid of patients with chronic eosinophilic pneumonia. Int Arch Allergy Immunol 137 (2005) 229-235
26. Miotto D., Christodoulopoulos P., Olivenstein R., et al. Expression of IFN-gamma-inducible protein monocyte chemotactic proteins 1, 3, and 4; and eotaxin in TH1- and TH2-mediated lung diseases. J Allergy Clin Immunol 107 (2001) 664-670
27. Sugiyama K., Mukae H., Ishii H., et al. Elevated levels of interferon gamma-inducible protein-10 and epithelial neutrophil-activating peptide-78 in patients with pulmonary sarcoidosis. Respilorogy 11 (2006) 708-714
28. Sallusto F., Lenig D., Mackay C.R., and Lanzavecchia A. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 187 (1998) 875-883
29. Deng W., Ohmori Y., and Hamilton T.A. Mechanisms of IL-4-mediated suppression of IP-10 gene expression in murine macrophages. J Immunol 153 (1994) 2130-2136
30. Hijnen D., De Bruin-Weller M., Oosting B., et al. Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell-attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis. J Allergy Clin Immunol 113 (2004) 334-340
31. Kakinuma T., Nakamura K., Wakugawa M., et al. Thymus and activation-regulated chemokine in atopic dermatitis: serum thymus and activation-regulated chemokine level is closely related with disease activity. J Allergy Clin Immunol 107 (2001) 535-541
32. Leung T.F., Wong C.K., Lam C.W., et al. Plasma TARC concentration may be a useful marker for asthmatic exacerbation in children. Eur Respir J 21 (2003) 616-620
33. Jahnz-Rozyk K., Targowski T., Paluchowska E., Owczarek W., and Kucharczyk A. Serum thymus and activation-regulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis. Allergy 60 (2005) 685-688
34. Weihrauch M.R., Manzke O., Beyer M., et al. Elevated serum levels of CC thymus and activation-related chemokine (TARC) in primary Hodgkin's disease: potential for a prognostic factor. Cancer Res 65 (2005) 5516-5519
35. Katoh S., Fukushima K., Matsumoto N., et al. Accumulation of CCR4-expressing CD4+ T cells and high concentration of its ligands (TARC and MDC) in bronchoalveolar lavage fluid of patients with eosinophilic pneumonia. Allergy 58 (2003) 518-523
36. Katchar K., Eklund A., and Grunewald J. Expression of Th1 markers by lung accumulated T cells in pulmonary sarcoidosis. J Intern Med 254 (2003) 564-571
37. Sgadari C., Farber J.M., Angiolillo A.L., et al. Mig, the monokine induced by interferon-gamma, promotes tumor necrosis in vivo. Blood 89 (1997) 2635-2643
38. Cole K.E., Strick C.A., Paradis T.J., et al. Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J Exp Med 187 (1998) 2009-2021
39. Lun S.W., Wong C.K., Ko F.W., Ip W.K., Hui D.S., and Lam C.W. Aberrant expression of CC and CXC chemokines and their receptors in patients with asthma. J Clin Immunol 26 (2006) 145-152
40. Fujii H., Shimada Y., Hasegawa M., Takehara K., and Sato S. Serum levels of a Th1 chemoattractant IP-10 and Th2 chemoattractants, TARC and MDC, are elevated in patients with systemic sclerosis. J Dermatol Sci 35 (2004) 43-51